Sisältöön - Papilloomavirusrokotetutkimus - Tampereen - Papilloomavirusrokotetutkimus - Tampereen yliopisto


This page is about the scientific background and achievements of HPV vaccination trials involving originally 59 000 12 to 18 year old Finnish girls and boys. The aims of the trials were to launch population-based cohorts for the determination of vaccine efficacy against the most stringed end-points and identification of the most effective vaccination strategies. You will find information about the HPV vaccination symposia and current videotaped lectures.

>> Video HPV Symposium 2012 lecture extracts

>> Interview : Nobel Prize laureate Dr Harald zur Hausen interviewed about HPV and HPV vaccination 

>> Publications

Tampereen yliopisto, Terveystieteiden yksikkö, Nuorisotutkimusasema, Sorinkatu 1, 33100 Tampere
Muutettu: 29.8.2012 15.40 Muokkaa